(CercleFinance.com) – Eurofins Scientific announces its intention to buy back its own shares for up to 2% of its capital, over a maximum period of 12 months, within the framework of the authorization granted by its extraordinary general meeting of April 2019.
The bio-analysis service provider reserves the right to discontinue this program if necessary. The shares thus repurchased will be used primarily to cover its long-term incentive plans, but may also be canceled or used to finance acquisitions.
An investment services provider has been appointed to execute the first tranche of this program, a tranche relating to a maximum of one million shares, ie 0.52% of the capital, and for a maximum duration of two months.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
